E-Mail
April 12, 2021 - For critically ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO), the risk of death remains high - but is much lower than suggested by initial studies, according to a report published today by
The findings support the use of ECMO as salvage therapy for COVID-19 patients with acute respiratory distress syndrome (ARDS) or respiratory failure who do not improve with conventional mechanical ventilatory support, according to the new research by Ninh T. Nguyen, MD, Chair of the Department of Surgery, University of California, Irvine Medical Center (UCIMC) and colleagues. Our findings refute previous reports of futility for ECMO therapy in the setting of COVID-19, states Fabio Sagebin, MD, of the UCIMC Division of Cardiothoracic Surgery.
Saha Legacy Continues with Establishment of New Research Center
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
Bruce Dalshaug: A life of extraordinary accomplishment and service
newsoptimist.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsoptimist.ca Daily Mail and Mail on Sunday newspapers.